340 related articles for article (PubMed ID: 26191211)
1. Abnormal intestinal permeability and microbiota in patients with autoimmune hepatitis.
Lin R; Zhou L; Zhang J; Wang B
Int J Clin Exp Pathol; 2015; 8(5):5153-60. PubMed ID: 26191211
[TBL] [Abstract][Full Text] [Related]
2. Leaky Gut Driven by Dysbiosis Augments Activation and Accumulation of Liver Macrophages
Zhang H; Liu M; Zhong W; Zheng Y; Li Y; Guo L; Zhang Y; Ran Y; Zhao J; Zhou L; Wang B
Front Immunol; 2021; 12():624360. PubMed ID: 33841405
[TBL] [Abstract][Full Text] [Related]
3. Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans.
Maccioni L; Gao B; Leclercq S; Pirlot B; Horsmans Y; De Timary P; Leclercq I; Fouts D; Schnabl B; Stärkel P
Gut Microbes; 2020 Nov; 12(1):1782157. PubMed ID: 32588725
[TBL] [Abstract][Full Text] [Related]
4. Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modulating the gut microbiota.
Yang H; Liu Q; Liu H; Kang X; Tian H; Kang Y; Li L; Yang X; Ren P; Kuang X; Wang X; Guo L; Tong M; Ma J; Fan W
Hepatol Commun; 2024 Apr; 8(4):. PubMed ID: 38466881
[TBL] [Abstract][Full Text] [Related]
5. Alterations of gut microbiome in autoimmune hepatitis.
Wei Y; Li Y; Yan L; Sun C; Miao Q; Wang Q; Xiao X; Lian M; Li B; Chen Y; Zhang J; Li Y; Huang B; Li Y; Cao Q; Fan Z; Chen X; Fang JY; Gershwin ME; Tang R; Ma X
Gut; 2020 Mar; 69(3):569-577. PubMed ID: 31201284
[TBL] [Abstract][Full Text] [Related]
6. A disease-specific decline of the relative abundance of Bifidobacterium in patients with autoimmune hepatitis.
Liwinski T; Casar C; Ruehlemann MC; Bang C; Sebode M; Hohenester S; Denk G; Lieb W; Lohse AW; Franke A; Schramm C
Aliment Pharmacol Ther; 2020 Jun; 51(12):1417-1428. PubMed ID: 32383181
[TBL] [Abstract][Full Text] [Related]
7. Increased intestinal permeability and gut dysbiosis in the R6/2 mouse model of Huntington's disease.
Stan TL; Soylu-Kucharz R; Burleigh S; Prykhodko O; Cao L; Franke N; Sjögren M; Haikal C; Hållenius F; Björkqvist M
Sci Rep; 2020 Oct; 10(1):18270. PubMed ID: 33106549
[TBL] [Abstract][Full Text] [Related]
8. A Novel Synbiotic Alleviates Autoimmune Hepatitis by Modulating the Gut Microbiota-Liver Axis and Inhibiting the Hepatic TLR4/NF-κB/NLRP3 Signaling Pathway.
Kang Y; Kuang X; Yan H; Ren P; Yang X; Liu H; Liu Q; Yang H; Kang X; Shen X; Tong M; Li L; Wang X; Guo L; Ma J; Zhang F; Fan W
mSystems; 2023 Apr; 8(2):e0112722. PubMed ID: 36794950
[TBL] [Abstract][Full Text] [Related]
9. Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitis.
Czaja AJ
World J Gastroenterol; 2016 Nov; 22(42):9257-9278. PubMed ID: 27895415
[TBL] [Abstract][Full Text] [Related]
10.
Zhang H; Liu M; Liu X; Zhong W; Li Y; Ran Y; Guo L; Chen X; Zhao J; Wang B; Zhou L
Front Immunol; 2020; 11():569104. PubMed ID: 33123141
[TBL] [Abstract][Full Text] [Related]
11. Intestinal microbiome and permeability in patients with autoimmune hepatitis.
Cai W; Ran Y; Li Y; Wang B; Zhou L
Best Pract Res Clin Gastroenterol; 2017 Dec; 31(6):669-673. PubMed ID: 29566910
[TBL] [Abstract][Full Text] [Related]
12. Dysbiosis of the Duodenal Mucosal Microbiota Is Associated With Increased Small Intestinal Permeability in Chronic Liver Disease.
Raj AS; Shanahan ER; Tran CD; Bhat P; Fletcher LM; Vesey DA; Morrison M; Holtmann G; Macdonald GA
Clin Transl Gastroenterol; 2019 Aug; 10(8):e00068. PubMed ID: 31373933
[TBL] [Abstract][Full Text] [Related]
13. Alcoholic liver disease: the gut microbiome and liver cross talk.
Hartmann P; Seebauer CT; Schnabl B
Alcohol Clin Exp Res; 2015 May; 39(5):763-75. PubMed ID: 25872593
[TBL] [Abstract][Full Text] [Related]
14. Effects of chronic noise exposure on the microbiome-gut-brain axis in senescence-accelerated prone mice: implications for Alzheimer's disease.
Cui B; Su D; Li W; She X; Zhang M; Wang R; Zhai Q
J Neuroinflammation; 2018 Jun; 15(1):190. PubMed ID: 29933742
[TBL] [Abstract][Full Text] [Related]
15. Fecal Microbiota Transplantation Controls Progression of Experimental Autoimmune Hepatitis in Mice by Modulating the TFR/TFH Immune Imbalance and Intestinal Microbiota Composition.
Liang M; Liwen Z; Jianguo S; Juan D; Fei D; Yin Z; Changping W; Jianping C
Front Immunol; 2021; 12():728723. PubMed ID: 34912328
[TBL] [Abstract][Full Text] [Related]
16. Evidence for tight junction protein disruption in intestinal mucosa of malignant obstructive jaundice patients.
Wang N; Yu H; Ma J; Wu W; Zhao D; Shi X; Tian H; Jiang H
Scand J Gastroenterol; 2010; 45(2):191-9. PubMed ID: 20095884
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota diversity predicts immune status in HIV-1 infection.
Nowak P; Troseid M; Avershina E; Barqasho B; Neogi U; Holm K; Hov JR; Noyan K; Vesterbacka J; Svärd J; Rudi K; Sönnerborg A
AIDS; 2015 Nov; 29(18):2409-18. PubMed ID: 26355675
[TBL] [Abstract][Full Text] [Related]
18. Probiotics alleviate autoimmune hepatitis in mice through modulation of gut microbiota and intestinal permeability.
Liu Q; Tian H; Kang Y; Tian Y; Li L; Kang X; Yang H; Wang Y; Tian J; Zhang F; Tong M; Cai H; Fan W
J Nutr Biochem; 2021 Dec; 98():108863. PubMed ID: 34517094
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota changes and chronic hepatitis C virus infection.
Preveden T; Scarpellini E; Milić N; Luzza F; Abenavoli L
Expert Rev Gastroenterol Hepatol; 2017 Sep; 11(9):813-819. PubMed ID: 28621554
[TBL] [Abstract][Full Text] [Related]
20. Unveiling the interplay between NSAID-induced dysbiosis and autoimmune liver disease in children: insights into the hidden gateway to autism spectrum disorders. Evidence from
Mohamed DI; Abo Nahas HH; Elshaer AM; El-Waseef DAEA; El-Kharashi OA; Mohamed SMY; Sabry YG; Almaimani RA; Almasmoum HA; Altamimi AS; Ibrahim IAA; Alshawwa SZ; Jaremko M; Emwas AH; Saied EM
Front Cell Neurosci; 2023; 17():1268126. PubMed ID: 38026692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
